Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun. 2019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tansley SL, Simou S, Shaddick G, Betteridge ZE, Almeida B, Gunawardena H, et al. Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun. 2017;84:55–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine. 2013;92(4):223–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tansley SL, Snowball J, Pauling JD, Lissina A, Kuwana M, Rider LG, et al. The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis. Arthritis Res Therapy. 2020;22(1):117.

Article  Google Scholar 

Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, et al. International guideline for idiopathic inflammatory myopathy-associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative. Nat Rev Rheumatol. 2023;19(12):805–17.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Zheng Y, Hao H, Yuan Y. Narrative review of autoantibodies in idiopathic inflammatory myopathies. Ann Transl Med. 2023;11(7):291.

Article  CAS  PubMed  Google Scholar 

Shinoda K, Okumura M, Yamaguchi S, Matsui A, Tsuda R, Hounoki H, et al. A comparison of line blots, enzyme-linked immunosorbent, and RNA-immunoprecipitation assays of antisynthetase antibodies in serum samples from 44 patients. Intern Med. 2022;61(3):313–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi MY, Satoh M, Fritzler MJ. Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies. Curr Opin Rheumatol. 2023;35(6):383–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghirardello A, Gatto M, Franco C, Zanatta E, Padoan R, Ienna L, et al. Detection of Myositis autoantibodies by multi-analytic immunoassays in a large multicenter cohort of patients with definite idiopathic inflammatory myopathies. Diagnostics. 2023;13:19.

Article  Google Scholar 

Preger C, Notarnicola A, Hellström C, Wigren E, Fernandes-Cerqueira C, Kvarnström M, et al. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies. J Autoimmun. 2023;134:102951.

Article  CAS  PubMed  Google Scholar 

Norimatsu Y, Matsuda KM, Yamaguchi K, Ono C, Okumura T, Kogo E, et al. The autoantibody array assay: a novel autoantibody detection method. Diagnostics. 2023;13:18.

Article  Google Scholar 

Kuzumi A, Norimatsu Y, Matsuda KM, Ono C, Okumura T, Kogo E, et al. Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. Front Immunol. 2023;14:1255540.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su Z, Wang L, Gao X, Huang Z, Hu J, Yang B. Clinical performance of the line immunoassay, digital liquid chip method, and chemiluminescent immunoassay for detecting specific antinuclear antibodies. Arch Pathol Lab Med. 2024;148(5):566–72.

Article  CAS  PubMed  Google Scholar 

Fiorentino DF, Gutierrez-Alamillo L, Hines D, Yang Q, Casciola-Rosen L. Distinct dermatomyositis populations are detected with different autoantibody assay platforms. Clin Exp Rheumatol. 2019;37(6):1048–51.

PubMed  PubMed Central  Google Scholar 

Beaton TJ, Gillis D, Prain K, Morwood K, Anderson J, Goddard J, et al. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review. Int J Rheum Dis. 2021;24(9):1167–75.

Article  CAS  PubMed  Google Scholar 

Platteel ACM, Wevers BA, Lim J, Bakker JA, Bontkes HJ, Curvers J, et al. Frequencies and clinical associations of myositis-related antibodies in the Netherlands: a one-year survey of all Dutch patients. J Transl Autoimmun. 2019;2:100013.

Article  PubMed  PubMed Central  Google Scholar 

Mulhearn B, Li D, McMorrow F, Lu H, McHugh NJ, Tansley SL. A commercial Anti-TIF1γ ELISA is Superior to line and dot blot and should be considered as part of routine myositis-specific antibody testing. Front Immunol. 2022;13:804037.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tansley SL, Li D, Betteridge ZE, McHugh NJ. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity. Rheumatology. 2020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bundell C, Rojana-Udomsart A, Mastaglia F, Hollingsworth P, McLean-Tooke A. Diagnostic performance of a commercial immunoblot assay for myositis antibody testing. Pathology. 2016;48(4):363–6.

Article  CAS  PubMed  Google Scholar 

Galindo-Feria AS, Wang G, Lundberg IE. Autoantibodies: pathogenic or epiphenomenon. Best Pract Res Clin Rheumatol. 2022;36(2):101767.

Article  PubMed  Google Scholar 

Pluk H, van BJA Hoeve, van SHJ Dooren, J Stammen-Vogelzangs et al. Autoantibodies to cytosolic 5’-nucleotidase 1A in inclusion body myositis. Ann Neurol. 2013;73(3):397–407.

Vulsteke J-B, Derua R, Dubucquoi S, Coutant F, Sanges S, Goncalves D, et al. Mass spectrometry-based identification of new anti-ly and known antisynthetase autoantibodies. Ann Rheum Dis. 2023;82(4):546–55.

Article  CAS  PubMed  Google Scholar 

Hosono Y, Sie B, Pinal-Fernandez I, Pak K, Mecoli CA, Casal-Dominguez M, et al. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies. Ann Rheum Dis. 2023;82(2):246–52.

Article  CAS  PubMed  Google Scholar 

Damoiseaux J, Vulsteke JB, Tseng CW, Platteel ACM, Piette Y, Shovman O, et al. Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays. Autoimmun rev. 2019;18(3):293–305.

Article  CAS  PubMed  Google Scholar 

Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the international consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis. 2019;78(7):879–89.

Article  CAS  PubMed  Google Scholar 

Yoshida K, Takahashi S, Kawai R, Saito T, Hatachi S, Shintani A, et al. Combination of cytoplasmic and nuclear patterns on Hep-2 antinuclear antibody is useful as a screening test for anti-synthetase syndrome. Rheumatology. 2024;63(9):2590–6. https://doi.org/10.1093/rheumatology/keae245.

Article  PubMed  Google Scholar 

Zanframundo G, Faghihi-Kashani S, Scirè CA, Bonella F, Corte TJ, Doyle TJ, et al. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022;40(2):309–19.

Article  PubMed  PubMed Central  Google Scholar 

Loganathan A, Zanframundo G, Yoshida A, Faghihi-Kashani S, Bauer Ventura I, Dourado E, et al. Agreement between local and central anti-synthetase antibodies detection: results from the classification criteria of anti-synthetase syndrome project biobank. Clin Exp Rheumatol. 2024;42(2):277–87.

PubMed  Google Scholar 

Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Investig. 1993;91(6):2556–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fritzler MJ, Bentow C, Satoh M, McHugh N, Ghirardello A, Mahler M. Deciphering the autoantibody response to the OJ antigenic complex. Diagnostics. 2023;13(1).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sasai T, Nakashima R